Cellectar stock price

Cellectar Biosciences Stock Quote: CLRB Stock News, Quotes ...

Cellectar Biosciences Inc. Stock Price (CLRB) | Barron's View today's stock price, news and analysis for Cellectar Biosciences Inc. (CLRB). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation CLRB: Cellectar Biosciences Inc - Stock Price, Quote and ... Get Cellectar Biosciences Inc (CLRB:NASDAQ) real-time stock quotes, news and financial information from CNBC. CLRB Stock Price and Chart — NASDAQ:CLRB — TradingView

Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer

Cellectar Biosciences Inc (CLRB) Quote | Morningstar Learn about CLRB with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CLRB. CLRB - Cellectar Biosc Stock Barchart Opinion - Barchart.com The Last Price shown is the last trade price at the time the quote page was displayed, and will not update every 10 seconds (as the Last Price at the top of the Quote page does). The Last Price will update only when the page is refreshed. Pivot points are used to identify …

Free current stock price quotes and data for Cellectar Biosciences Inc (CLRB). Research news, charts, stock market performance and earnings.

Nov 08, 2019 · CLRB, Cellectar Biosciences - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Cellectar Biosciences Stock Chart - CLRB Cellectar Biosciences (CLRB) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

CLRBZ | Complete Cellectar Biosciences Inc. Wt Series A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer Cellectar Biosciences Inc (CLRB) Quote | Morningstar Learn about CLRB with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CLRB. CLRB - Cellectar Biosc Stock Barchart Opinion - Barchart.com The Last Price shown is the last trade price at the time the quote page was displayed, and will not update every 10 seconds (as the Last Price at the top of the Quote page does). The Last Price will update only when the page is refreshed. Pivot points are used to identify … NVLTD Stock Quote - Cellectar Biosciences Inc - Bloomberg ...

Cellectar Biosciences, Inc. (CLRB)

View the real-time CLRB price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Cellectar Biosciences against related stocks people have also bought like NIO, GERN, ACB, and OGEN. 869 people own Cellectar Biosciences on Robinhood on April 4, 2020. CLRB - Stock quote for CELLECTAR BIOSCIENCES, INC. - MSN … View the latest CLRB stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CELLECTAR BIOSCIENCES, INC.. Cellectar BioSciences (CLRB) Stock Price History | wallmine

Learn about CLRB with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a Stock Style. Large-Cap  Cellectar Biosciences (Nasdaq: CLRB) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and  Our common stock is listed on the Nasdaq Capital Market under the symbol “ CLRB.” On November 22, 2016, the last reported sale price of our common stock on  Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment  Stock splits are used by Cellectar Biosciences, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets   Based on 3 analysts offering 12 month price targets for Cellectar Biosciences in the last 3 months. The average price target is $6.33 with a high forecast of